Approvals/CIMA-AEMPS/ALYFTREK 50 MG/20 MG/4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

ALYFTREK 50 MG/20 MG/4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Vertex Pharmaceuticals (Ireland) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 2a0273554c658cba
Drug Cima Aemps Name: ALYFTREK 50 MG/20 MG/4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 1251943001
Holder Company Name: Vertex Pharmaceuticals (Ireland) Limited
Marketing Company Name: Vertex Pharmaceuticals (Spain) S.L.
Holder Company Detail Path: /organization/vertex-pharmaceuticals-ireland-limited
Authorization Date: 2025-08-13
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 50 mg/20 mg/4 mg
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Vertex Pharmaceuticals (Ireland) Limited
Company Detail Path: /organization/vertex-pharmaceuticals-ireland-limited

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Aug 13, 2025

Approval ID

2a0273554c658cba

Type

Standard